Ikarovec

Ikarovec

Ikarovec

Ikarovek is working on early stage assets intended for the treatment of diabetic macular edama.
Raised
$3.3M
Follow us
Alexa global traffic share
Latest funding
£2,500,000
Seed fund - 2020
LifeArc UK Innovation & Science Seed Fund (UKI2S) Parkwalk
Team Size
1–10
Employees
£2,500,000 Seed fund
FinSMEs

Ikarovec Raises £2.5M in Seed Funding